Jiangsu East Mab Biotechnology Co. LTD was founded by a team of senior experts in the biomedical industry. It was founded in Nantong, Jiangsu in 2016. Currently, it has two R & D and production bases in Suzhou and Nantong. The company focuses on the production of in vitro diagnostic proteins, target proteins, industrial enzymes and cytokines. The company is a national high-tech enterprise and has passed the ISO9001 international quality system certification. The company has 3000 square meters of GMP standard protein production workshop, 4000 square meters of research and development laboratory, and protein expression platform based on Escherichia coli, yeast, insects and mammalian cells (CHO-k1/293). At the same time, the company also has single-cell (human, mouse, rat, rabbit, alpaca, camel, monkey) antibody/all-natural humanized technology platform, bispecific antibody technology platform, antibody glycosylation (fucose knockout) And antibody modification technology platform, nano-antibody technology platform, with raw protein/antibody modification related technology patents and 16 soft works. The company is positioned as a manufacturer of core protein raw materials in the biomedical industry. It will continue to maintain technology and market investment, adhere to the concept of "responsibility, focus, innovation, and development", meticulous and refined attitude, with a professional R & D team and first-class hardware supporting facilities, Strict product quality control system provides high-quality services for global drug research and development companies, diagnostic reagent companies, and scientific researchers.